Cargando…

PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients

Detalles Bibliográficos
Autores principales: Marques, R, Ramos, F, Perpétuo, I, Fernandes, S, Furtado, C, Mourão, AF, Martins, F, Canhão, H, Fonseca, JE, Pereira da Silva, JA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043502/
http://dx.doi.org/10.1186/1546-0096-11-S2-P107
_version_ 1782318916675043328
author Marques, R
Ramos, F
Perpétuo, I
Fernandes, S
Furtado, C
Mourão, AF
Martins, F
Canhão, H
Fonseca, JE
Pereira da Silva, JA
author_facet Marques, R
Ramos, F
Perpétuo, I
Fernandes, S
Furtado, C
Mourão, AF
Martins, F
Canhão, H
Fonseca, JE
Pereira da Silva, JA
author_sort Marques, R
collection PubMed
description
format Online
Article
Text
id pubmed-4043502
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40435022014-06-17 PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients Marques, R Ramos, F Perpétuo, I Fernandes, S Furtado, C Mourão, AF Martins, F Canhão, H Fonseca, JE Pereira da Silva, JA Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4043502/ http://dx.doi.org/10.1186/1546-0096-11-S2-P107 Text en Copyright © 2013 Marques et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Marques, R
Ramos, F
Perpétuo, I
Fernandes, S
Furtado, C
Mourão, AF
Martins, F
Canhão, H
Fonseca, JE
Pereira da Silva, JA
PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
title PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
title_full PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
title_fullStr PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
title_full_unstemmed PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
title_short PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
title_sort pres-final-2095: older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043502/
http://dx.doi.org/10.1186/1546-0096-11-S2-P107
work_keys_str_mv AT marquesr presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT ramosf presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT perpetuoi presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT fernandess presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT furtadoc presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT mouraoaf presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT martinsf presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT canhaoh presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT fonsecaje presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients
AT pereiradasilvaja presfinal2095olderagepredictspoorresponseto6monthsmethotrexatetherapyinajuvenileidiopathicarthritiscohortofpatients